|
|
|
Insider
Information: |
Roberts Bryan E |
Relationship: |
|
City: |
Menlo Park |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
9 |
|
Direct
Shares |
133,663 |
|
Indirect Shares
|
17,084,048 |
|
|
Direct
Value |
$207,362 |
|
|
Indirect Value
|
$667,770,104 |
|
|
Total
Shares |
17,217,711 |
|
|
Total
Value |
$667,977,466 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Xenoport Inc |
XNPT |
Director |
2007-05-10 |
5 |
2007-05-10 |
1,022,233 |
Premium* |
|
Neurocrine Biosciences Inc |
NBIX |
10% Owner |
|
0 |
2009-12-22 |
4,784,689 |
Premium* |
|
Ironwood Pharmaceuticals Inc |
IRWD |
Director |
2015-06-15 |
31,951 |
2015-06-15 |
92,027 |
Premium* |
|
Chelsea Therapeutics Internation... |
CHTP |
10% Owner |
2010-09-20 |
0 |
2011-02-02 |
5,189,934 |
Premium* |
|
Zeltiq Aesthetics Inc |
ZLTQ |
Director |
2015-11-04 |
13,204 |
2015-11-04 |
0 |
Premium* |
|
Achaogen Inc |
AKAO |
Director, 10% Owner |
2014-03-17 |
0 |
2014-03-17 |
1,746,461 |
Premium* |
|
Vitae Pharmaceuticals, Inc |
VTAE |
Director, 10% Owner |
2014-09-29 |
0 |
2014-09-29 |
47,077 |
Premium* |
|
Castlight Health, Inc. |
CSLT |
Director, 10% Owner |
2022-02-17 |
0 |
2022-02-17 |
0 |
Premium* |
|
10x Genomics, Inc. |
TXG |
|
2023-06-14 |
88,503 |
2023-06-14 |
4,201,627 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
122 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
IRWD |
Ironwood Pharmaceuticals ... |
Director |
|
2014-03-14 |
4 |
A |
$12.76 |
$2,488 |
D/D |
195 |
24,555 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Director |
|
2014-05-30 |
4 |
S |
$14.52 |
$5,969,956 |
I/I |
(411,154) |
78,007 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Director |
|
2014-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
19,778 |
44,333 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Director |
|
2014-06-09 |
4 |
S |
$14.52 |
$4,194,044 |
I/I |
(288,846) |
31,914 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Director |
|
2014-06-12 |
4 |
S |
$14.24 |
$2,848,000 |
I/I |
(200,000) |
0 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Director |
|
2014-06-13 |
4 |
A |
$14.66 |
$2,492 |
D/D |
170 |
44,503 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Director |
|
2014-08-22 |
4 |
A |
$0.00 |
$0 |
I/I |
1,955,994 |
36,290 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Director |
|
2014-08-22 |
4 |
A |
$0.00 |
$0 |
I/I |
1,955,994 |
0 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Director |
|
2014-09-15 |
4 |
A |
$12.59 |
$2,493 |
D/D |
198 |
15,219 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Director |
|
2014-12-12 |
4 |
S |
$15.21 |
$282,784 |
I/I |
(18,592) |
17,698 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Director |
|
2014-12-15 |
4 |
A |
$13.70 |
$2,493 |
D/D |
182 |
15,401 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Director |
|
2014-12-15 |
4 |
S |
$15.06 |
$18,072 |
I/I |
(1,200) |
16,498 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Director |
|
2015-03-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,936,202) |
0 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Director |
|
2015-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
64 |
15,085 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Director |
|
2015-03-03 |
4 |
A |
$0.00 |
$0 |
I/I |
148 |
253 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Director |
|
2015-03-09 |
4 |
S |
$15.62 |
$103,907 |
I/I |
(6,648) |
6,975 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Director |
|
2015-03-10 |
4 |
S |
$15.07 |
$1,355,429 |
I/I |
(89,350) |
0 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Director |
|
2015-03-13 |
4 |
A |
$15.07 |
$2,487 |
D/D |
165 |
15,250 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Director |
|
2015-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
16,556 |
31,806 |
0 |
- |
|
IRWD |
Ironwood Pharmaceuticals ... |
Director |
|
2015-06-15 |
4 |
A |
$12.06 |
$1,749 |
D/D |
145 |
31,951 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
10% Owner |
|
2009-12-22 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
4,784,689 |
|
- |
|
VTAE |
Vitae Pharmaceuticals, In... |
Director |
|
2014-09-29 |
4 |
B |
$8.00 |
$6,178,664 |
I/I |
772,333 |
47,077 |
2.25 |
- |
|
VTAE |
Vitae Pharmaceuticals, In... |
Director |
|
2014-09-29 |
4 |
A |
$0.00 |
$0 |
I/I |
1,581,870 |
31,631 |
0 |
- |
|
XNPT |
Xenoport Inc |
Director |
|
2005-06-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
56,700 |
|
- |
|
XNPT |
Xenoport Inc |
Director |
|
2005-06-07 |
4/A |
A |
$0.00 |
$0 |
I/I |
173,774 |
836,900 |
|
- |
|
122 Records found
|
|
Page 4 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|